Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verastem (VSTM) Total Non-Current Liabilities (2018 - 2025)

Historic Total Non-Current Liabilities for Verastem (VSTM) over the last 6 years, with Q3 2025 value amounting to $144.1 million.

  • Verastem's Total Non-Current Liabilities rose 11182.58% to $144.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $144.1 million, marking a year-over-year increase of 11182.58%. This contributed to the annual value of $72.2 million for FY2024, which is N/A changed from last year.
  • Per Verastem's latest filing, its Total Non-Current Liabilities stood at $144.1 million for Q3 2025, which was up 11182.58% from $138.5 million recorded in Q2 2025.
  • Verastem's Total Non-Current Liabilities' 5-year high stood at $144.1 million during Q3 2025, with a 5-year trough of $68.0 million in Q3 2024.
  • Over the past 3 years, Verastem's median Total Non-Current Liabilities value was $90.8 million (recorded in 2024), while the average stood at $100.7 million.
  • In the last 5 years, Verastem's Total Non-Current Liabilities plummeted by 521.44% in 2024 and then skyrocketed by 11182.58% in 2025.
  • Verastem's Total Non-Current Liabilities (Quarter) stood at $71.8 million in 2023, then rose by 0.65% to $72.2 million in 2024, then surged by 99.48% to $144.1 million in 2025.
  • Its Total Non-Current Liabilities stands at $144.1 million for Q3 2025, versus $138.5 million for Q2 2025 and $109.4 million for Q1 2025.